169 related articles for article (PubMed ID: 3079072)
1. Cyclosporine immunosuppression and perfusion preservation of cadaver kidneys.
Bradley JW; Cho SI; Cosimi AB; Monaco AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2104-5. PubMed ID: 3079072
[No Abstract] [Full Text] [Related]
2. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
3. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
[No Abstract] [Full Text] [Related]
4. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
[No Abstract] [Full Text] [Related]
5. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
6. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
Schweizer RT; Rovelli M; Roper L; Bartus SA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
[No Abstract] [Full Text] [Related]
7. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
Simonton SC; Sibley RK; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
[No Abstract] [Full Text] [Related]
8. The role of antilymphocyte globulin in cadaver renal transplantation.
Novick AC
Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
[No Abstract] [Full Text] [Related]
9. Place of antilymphocyte globulins in the immunosuppressive regimen for kidney transplantation.
Touraine JL; Lefrançois N; Dubernard JM; Garnier JL; Eygonnet JP; Gibelin N; Bétuel H; Traeger J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1881. PubMed ID: 3079055
[No Abstract] [Full Text] [Related]
10. Quality of life on cyclosporine versus conventional therapy.
Simmons RG; Abress LK
Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
[No Abstract] [Full Text] [Related]
11. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
12. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
13. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
[No Abstract] [Full Text] [Related]
14. Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
Illner WD; Theodorakis J; Abendroth D; Schleibner S; Stangl M; Landgraf R; Land W
Transplant Proc; 1990 Aug; 22(4):1586-7. PubMed ID: 2117795
[No Abstract] [Full Text] [Related]
15. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
[No Abstract] [Full Text] [Related]
16. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
[No Abstract] [Full Text] [Related]
17. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
Light JA; Aquino A; Ali A; Rodriguez R; Ali S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
[No Abstract] [Full Text] [Related]
18. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
Blümke M; Kirste G; Wanner U; Wilms H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
[No Abstract] [Full Text] [Related]
19. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression in cardiac transplantation.
Rose EA; Addonizio LJ
Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
